文献速递主动脉疾病

胸腹主动脉瘤开窗/分支腔内修复患者的脊髓缺血发生率与预防性脊髓引流

Spinal cord ischemia rates and prophylactic spinal drainage in patients treated with fenestrated/branched endovascular repair for thoracoabdominal aneurysms.
PubMed 文献 · J Vasc Surg · 2023-06-12

单中心回顾性研究纳入2018年1月1日至2022年11月1日连续198例I至IV型胸腹主动脉瘤行开窗/分支腔内修复患者,围术期脊髓缺血发生率为4.5%,截瘫2.5%;I至III型中预防性脊髓引流组与治疗性脊髓引流组脊髓缺血、截瘫及无恢复截瘫发生率均无显著差异。

要点

  • 围术期脊髓缺血发生率为4.5%,其中截瘫2.5%。
  • 脊髓缺血组主要不良心血管事件发生率66.7% vs 7.9%(P < .001)。
  • I至III型中预防性脊髓引流未降低脊髓缺血发生率。

核心结论

  • I至IV型胸腹主动脉瘤腔内修复后脊髓缺血发生率低,脊髓缺血与主要不良心血管事件和重症监护室住院时间显著增加相关。
  • I至III型胸腹主动脉瘤预防性使用脑脊液引流与较低的脊髓缺血发生率无关,可能不需常规使用。

研究设计与样本

  • 遵循STROBE声明的单中心回顾性研究,纳入2018年1月1日至2022年11月1日连续198例I至IV型胸腹主动脉瘤(退行性及夹层后动脉瘤)行开窗/分支腔内修复的患者。
  • 排除近肾或肾旁动脉瘤以及因主动脉破裂或急性夹层紧急处理的患者。
  • 2020年后I至III型胸腹主动脉瘤放弃预防性脊髓引流,改为仅在出现脊髓缺血的患者中行治疗性脊髓引流。

主要发现

  • 平均年龄71.1±3.4岁,男性81.8%,I至III型占50.5%。
  • 主要技术成功率为94.9%,围术期死亡率为2.5%,主要不良心血管事件发生率为10.6%。
  • 脊髓缺血发生率为4.5%,其中截瘫2.5%。
  • 脊髓缺血组与其余队列相比,主要不良心血管事件发生率66.7% vs 7.9%(P < .001),重症监护室住院时间3.5天 vs 1天(P = .002)。
  • I至III型修复后,预防性脊髓引流组与治疗性脊髓引流组的脊髓缺血发生率7.3% vs 5.1%(P = .66)、截瘫发生率4.8% vs 3.3%(P = .72)、无恢复截瘫发生率2% vs 0%(P = .37)均无显著差异。

关键数值与推荐

  • 围术期脊髓缺血发生率为4.5%,截瘫发生率为2.5%。
  • 脊髓缺血组主要不良心血管事件发生率为66.7%,其余队列为7.9%(P < .001)。
  • 脊髓缺血组重症监护室住院时间3.5天,其余队列为1天(P = .002)。
  • I至III型中预防性脊髓引流组与治疗性脊髓引流组脊髓缺血发生率7.3% vs 5.1%(P = .66)。

临床怎么用

  • 作者认为I至III型胸腹主动脉瘤预防性使用脑脊液引流可能不需常规使用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Spinal cord ischemia (SCI) is a devastating complication after thoracoabdominal aortic aneurysm (TAAA) repair. The benefit of prophylactic cerebrospinal fluid drainage (pCSFD) to prevent SCI is still under investigation. The aim of this study was to evaluate the SCI rate and the impact of pCSFD following complex endovascular repair (fenestrated or branched endovascular repair [F/BEVAR]) for type I to IV TAAA. METHODS: The STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) statement was followed. A single-center retrospective study was conducted, including all consecutive patients, managed for TAAA type I to IV using F/BEVAR, between January 1, 2018, and November 1, 2022, for degenerative and post-dissection aneurysms. Patients with juxta- or pararenal aneurysms were excluded, as well as cases managed urgently for aortic rupture or acute dissection. After 2020, pCSFD in type I to III TAAAs was abandoned and replaced by therapeutic CSFD (tCSFD), performed only in patients presenting SCI. The primary outcome was the perioperative SCI rate for the entire cohort and the role of pCSFD for type I to III TAAAs. RESULTS: In total, 198 patients were included (mean age, 71.1±3.4 years; 81.8% males), including 50.5% with type I to III TAAA. The primary technical success was 94.9%. The perioperative mortality was 2.5%. and the major adverse cardiovascular event (MACE) rate was 10.6%; 4.5% presented SCI of any type (2.5% paraplegia). When comparing the SCI group with the remaining cohort, patients with SCI presented higher MACE (66.7% vs 7.9%; P < .001) rate and longer intensive care unit stay (3.5 vs 1 day; P = .002). Following type I to III repair, similar SCI, paraplegia, and paraplegia with no recovery rates were reported in the pCSFD and tCSFD groups (7.3% vs 5.1%; P = .66; 4.8% vs 3.3%; P = .72; and 2% vs 0%; P = .37). CONCLUSIONS: The incidence of SCI after TAAA I to IV endovascular repair was low. SCI was associated with significantly increased MACE and intensive care unit stay. The prophylactic use of CSFD in type I to III TAAAs was not associated with lower SCI rates and may not be justified routinely.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Locatelli F, Nana P, Le Houérou T, et al. Spinal cord ischemia rates and prophylactic spinal drainage in patients treated with fenestrated/branched endovascular repair for thoracoabdominal aneurysms. J Vasc Surg. 2023. PMID: 37315908. doi:10.1016/j.jvs.2023.06.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。